These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 6199441)
1. A newer hyperthermic therapy with a bacterial immunopotentiator (OK432) for chemotherapy-resistant ovarian cancer. Nishida T; Oda T; Sugiyama T; Yakushiji M; Kato T Nihon Sanka Fujinka Gakkai Zasshi; 1984 Jan; 36(1):142-6. PubMed ID: 6199441 [TBL] [Abstract][Full Text] [Related]
2. Second-look laparotomy in endodermal sinus tumor: a report of two patients with normal levels of alpha-fetoprotein and residual tumor at reexploration. Curtin JP; Rubin SC; Hoskins WJ; Hakes TB; Lewis JL Obstet Gynecol; 1989 May; 73(5 Pt 2):893-5. PubMed ID: 2468119 [TBL] [Abstract][Full Text] [Related]
3. [Modified VAB-3 combination chemotherapy of stage IV endodermal sinus tumor of the ovary]. Tsukamoto N; Imachi M; Sumioki H; Kamura T Gan To Kagaku Ryoho; 1984 Apr; 11(4):948-51. PubMed ID: 6202244 [TBL] [Abstract][Full Text] [Related]
4. Combination chemotherapy in the management of ovarian germ cell malignancies. Schwartz PE Obstet Gynecol; 1984 Oct; 64(4):564-72. PubMed ID: 6207473 [TBL] [Abstract][Full Text] [Related]
5. [Multimodal treatment for advanced, ovarian cancer patients with poor performance status--its effectiveness and limitations]. Shimizu Y; Tatsuki Y; Fujimoto I; Yamauchi K; Hasumi K; Masubuchi K Nihon Sanka Fujinka Gakkai Zasshi; 1992 Dec; 44(12):1551-8. PubMed ID: 1484219 [TBL] [Abstract][Full Text] [Related]
6. Cisplatin, vinblastine, and bleomycin combination chemotherapy in endodermal sinus tumor of the ovary. Sessa C; Bonazzi C; Landoni F; Pecorelli S; Sartori E; Mangioni C Obstet Gynecol; 1987 Aug; 70(2):220-4. PubMed ID: 2439966 [TBL] [Abstract][Full Text] [Related]
7. [An early combined endodermal sinus tumor of the ovary that was diagnosed due to torsion of serous cystadenoma--a case report]. Sawai H; Kawamoto M; Sonobe H Gan No Rinsho; 1989 Oct; 35(12):1473-8. PubMed ID: 2478734 [TBL] [Abstract][Full Text] [Related]
8. Alpha-fetoprotein production by a malignant mixed Müllerian tumor of the ovary. Rebischung C; Pautier P; Morice P; Lhomme C; Duvillard P Gynecol Oncol; 2000 Apr; 77(1):203-5. PubMed ID: 10739713 [TBL] [Abstract][Full Text] [Related]
9. [Cisplatin, vinblastine, and bleomycin combination chemotherapy in a stage IV pure endodermal sinus tumor of the ovary--a case report of a long-term survival]. Saito N; Kashimura Y; Soh T; Tsukamoto N Gan No Rinsho; 1988 Dec; 34(15):2114-8. PubMed ID: 2466134 [TBL] [Abstract][Full Text] [Related]
10. [Whole abdominal irradiation of ovarian cancer in combined treatment with OK-432 picibanil]. Morita S; Arai T; Tsunemoto H Gan No Rinsho; 1986 Jan; 32(1):71-5. PubMed ID: 3005691 [TBL] [Abstract][Full Text] [Related]
11. The diagnosis of immature teratoma by maternal serum alpha-fetoprotein screening. Montz FJ; Horenstein J; Platt LD; d'Ablaing G; Schlaerth JB; Cunningham G Obstet Gynecol; 1989 Mar; 73(3 Pt 2):522-5. PubMed ID: 2464780 [TBL] [Abstract][Full Text] [Related]
12. An attempt of hyperthermia with balloon catheter and immunochemotherapeutic agent. Yamada R; Tsuji K; Kishi K; Suwa K; Mitsuzane K; Tanaka K; Satoh M; Kawabata M; Maeda M Radiat Med; 1988; 6(2):79-84. PubMed ID: 2845485 [TBL] [Abstract][Full Text] [Related]
13. [Cytoreductive surgery and intraperitoneal hyperthermic-antiblastic therapy (HAPP) in peritoneal carcinomatosis]. Vaira M; Scuderi S; Costamagna D; Barone R; Aghemo B; Mioli PR; De Simone M Minerva Chir; 2002 Oct; 57(5):597-605. PubMed ID: 12370661 [TBL] [Abstract][Full Text] [Related]
14. Adjuvant immunotherapy with a S. pyogenes preparation (OK432) in urogenital cancer patients. Nakagami Y; Chin H; Tannowa K; Matsumoto K; Kawai H Invest Urol; 1980 Mar; 17(5):386-9. PubMed ID: 6965669 [TBL] [Abstract][Full Text] [Related]
15. [Experimental and clinical study of adoptive immunotherapy combined with preadministration of OK-432: a method to augment the therapeutic effect]. Kan N; Okino T; Nakanishi M; Sato K; Mise K; Teramura Y; Yamasaki S; Hori T; Ohgaki K; Tobe T Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-2):1455-61. PubMed ID: 2786379 [TBL] [Abstract][Full Text] [Related]
16. Yolk sac tumor of the ovary during pregnancy: a case report. Aoki Y; Higashino M; Ishii S; Tanaka K Gynecol Oncol; 2005 Nov; 99(2):497-9. PubMed ID: 16051324 [TBL] [Abstract][Full Text] [Related]
17. Management of advanced endodermal sinus tumor of the ovary with preservation of reproductive function. Hicks ML; Maxwell SL; Kim W Henry Ford Hosp Med J; 1990; 38(1):76-8. PubMed ID: 2228718 [TBL] [Abstract][Full Text] [Related]
18. [Analysis of serum CA125, CEA, AFP, LDH levels and LDH isoenzymes in patients with ovarian tumors--correlation between tumor markers and histological types of ovarian tumors]. Konishi I; Fujii S; Okamura H; Sakahara H; Endo K; Torizuka K; Suzuki A; Mori T Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jun; 38(6):827-36. PubMed ID: 2426374 [TBL] [Abstract][Full Text] [Related]
19. [An experience of OK-432 intradermal administration in superficial bladder tumors]. Tsujihashi H; Akiyama T; Kurita T; Iguchi M; Uejima S; Kataoka K; Minakata S; Kitagawa M; Sangen H Hinyokika Kiyo; 1988 Dec; 34(12):2111-4. PubMed ID: 3239522 [TBL] [Abstract][Full Text] [Related]
20. [Effect of immunotherapy using the non-specific immunopotentiator OK-432 in malignant ovarian tumors--selecting appropriate cases for immunotherapy]. Nishida Y; Sakakibara K; Kano T; Ohta M; Tomoda Y Nihon Sanka Fujinka Gakkai Zasshi; 1986 Jul; 38(7):1017-25. PubMed ID: 3746020 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]